About Admin

David experienced an adverse event to the the fluoroquinolone Levaquin in 2007 at age 46. Prior to, he was a healthy law enforcement official. Now, disabled with drug induced mitochondrial disease/dysfunction, he is an FQ patient safety advocate, citizen scientist, FQ researcher, author, and commentator. He has contributed to case studies and published academic papers on the FQ’s in the BMJ, European Journal of Medicine, The Journal of Community and Supportive Oncology, Oxford Academic Clinical infectious Diseases, and contributed data to many more outlets.

Another Milestone Crossed: Fluoroquinolones, The FDA, and Psychiatric Adverse Events

In an astonishing statement from the FDA, they acknowledged that since “Psychiatric Effects” will specifically be identified within the “Central Nervous System Effects” subheading, psychiatric adverse events are automatically assumed to be part of the existing Black Box warning.

Another Brush With Death: Returning From The Brink

To those who are new to my plight or are unfamiliar with my personal situation, my life is delineated with a clear demarcation line. The life before taking Levaquin, a fluoroquinolone (FQ) antibiotic, and my life after. My healthy life before and my not so healthy life after. It is my story, my quin story, my life after Levaquin; Extremely healthy in one season, and a struggle with health the next.